MedTrace Logo

Temporomandibular Joint and COVID-19

NCT05077189 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 76

Last updated 2021-10-21

No results posted yet for this study

Summary

There is evidence that CV-19 is associated with joint symptoms, but there are no specific data on the temporomandibular joint (TMJ). It is also known that the systemic health status can impact the immune system. Given all this, this study aimed to investigate the effect of CV-19 and systemic health status, as determined by the American Society of Anesthesiologists (ASA) Physical Status Classification System 12, on TMJ in patients with TMJ complaints using the DC/TMD scale.

Conditions

  • COVID-19
  • Temporomandibular Disorder
  • ASA Triad

Interventions

OTHER

Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) scale

4 items of the DC/TMD scale were used in this study to evaluate the TMJ disorders. 1. Demographics Survey 2. DC/TMD Symptom Questionnaire (SQ) 3. Graded Chronic Pain Scale (GCPS) 4. Jaw Functional Limitation Scale-20 (JFLS-20)

Sponsors & Collaborators

  • Recep Tayyip Erdogan University Training and Research Hospital

    lead OTHER

Principal Investigators

  • Nazife B Karan · Recep Tayyip Erdogan University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2021-03-01
Completion
2021-06-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05077189 on ClinicalTrials.gov